相关实验视频

Updated: Jul 11, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

针对多抑制基因的合成阅读器-执行器阻止了三阴性乳腺癌的扩散和入侵

Lauren Hong¹, Natecia L Williams², Maya Jaffe¹

¹Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, Georgia, USA; and Emory University, Atlanta, Georgia, USA.

GEN biotechnology

|November 6, 2023

概括

科学家们开发了一种合成阅读器-执行器 (SRA),以准多组合染色体,重新激活瘤抑制基因. 这种方法对通过抑制癌症的扩散和入侵来治疗三阴性乳腺癌 (TNBC) 是有前途的.

科学领域:

表观遗传学在表观遗传学中,表观遗传学是指表观遗传学.
癌症生物学癌症生物学
分子治疗学分子治疗学

背景情况:

针对多组蛋白的药理抑制剂旨在恢复瘤抑制基因表达,但由于TP53.3等关键转录激活器的突变而面临限制.
在固体癌症,包括三阴性乳腺癌 (TNBC) 中,聚基向治疗的不良临床结果阻碍了表观遗传单一治疗的发展.

研究的目的:

开发一种新型的合成阅读器-执行器 (SRA),通过准多组组染色体来对表观基因组进行执行.
调查SRA调节核心转录激活器和恢复TNBC细胞中瘤抑制基因表达的能力.

主要方法:

使用合成阅读器-执行器 (SRA) 进行表观基因组激活,该激活器旨在结合三甲基化素H3素 27.
利用TNBC BT-549细胞和球体来评估基因表达变化和表型变化.

主要成果:

在TNBC BT-549细胞中SRA表达导致122个基因的≥2倍上调,包括那些参与细胞死亡,细胞循环停止和迁移抑制的基因.
在Matrigel中,表达SRA的球状体体积减小,侵入力减弱,这表明抑制了癌细胞的侵入性.

结论:

向调解器-招募调节器到沉默的染色质可以激活瘤抑制剂并促进抗癌表型.
进一步开发像SRA这样强大的基因调节剂可能为三阴性乳腺癌患者提供治疗效益.

更多相关视频

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model

Published on: March 20, 2020

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

Experimental RNAi

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...